1 Min Read
May 2 (Reuters) - Moberg Pharma AB (publ):
* MOBERG PHARMA ESTIMATES THAT PRODUCT HAS A SALES POTENTIAL AMOUNTING TO USD 100-200 MILLION ANNUALLY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.